Clinical characteristics, disease activity, functional status, and quality of life results of patients with psoriatic arthritis using biological and conventional synthetic disease-modifying antirheumatic drugs
ARCHIVES OF RHEUMATOLOGY, cilt.36, sa.1, ss.1-9, 2021 (SCI İndekslerine Giren Dergi)
Makale / Tam Makale
ARCHIVES OF RHEUMATOLOGY
Objectives: This study aims to compare the clinical characteristics, disease activity, and quality of life (QoL) of patients with psoriatic arthritis (PsA) who use biological and conventional synthetic disease-modifying antirheumatic drugs (DMARDs) in a nationwide cohort throughout Turkey.